Review: On TRAIL for malignant glioma therapy?

J. M. A. Kuijlen, E. Bremer, J. J. A. Mooij, W. F. A. den Dunnen and W. Helfrich (2010) Neuropathology and Applied Neurobiology36, 168–182 On TRAIL for malignant glioma therapy? Glioblastoma (GBM) is a devastating cancer with a median survival of around 15 months. Significant advances in treatment h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropathology and applied neurobiology 2010-04, Vol.36 (3), p.168-182
Hauptverfasser:	Kuijlen, J. M. A., Bremer, E., Mooij, J. J. A., Den Dunnen, W. F. A., Helfrich, W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals apoptosis Apoptosis - genetics Apoptosis - physiology Biological and medical sciences combination therapy GBM Glioma - metabolism Glioma - therapy Humans Medical sciences Models, Neurological Nervous system (semeiology, syndromes) Nervous system as a whole Neurology Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism review targeting TNF-Related Apoptosis-Inducing Ligand - genetics TNF-Related Apoptosis-Inducing Ligand - metabolism TNF-Related Apoptosis-Inducing Ligand - therapeutic use TRAIL
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!